Daiichi Sankyo Europe GmbH is the European subsidiary of the global pharmaceutical company Daiichi Sankyo Co., Ltd., headquartered in Tokyo. It is a research-based pharmaceutical company focused on developing and delivering new standards in healthcare, particularly in oncology and cardiovascular diseases. The company operates in multiple European countries and Canada, contributing to the improvement of lives through its scientific expertise and innovative medicines.